Dietary flavonoids fail to suppress F2-isoprostane formation in vivo.

Willcox JK, Catignani GL, Roberts LJ
Free Radic Biol Med. 2003 34 (7): 795-9

PMID: 12654466 · DOI:10.1016/s0891-5849(02)01425-9

Dietary antioxidants, including alpha-tocopherol (alpha-TOH) and polyphenolic flavonoid compounds, have been the subject of much research interest, but few studies have investigated interactions between these two antioxidants in vivo. We have conducted a feeding study to determine if supplementation with dietary flavonoids or polyphenol-containing compounds will provide antioxidant protection in tocopherol-deficient animals or exceed the antioxidant protection provided by alpha-TOH alone, using the sensitive and specific measure of lipid peroxidation, F2-isoprostanes. Seventy-two male Sprague Dawley rats were divided into 12 treatment groups to receive either alpha-TOH-sufficient or -deficient AIN93-G diet supplemented with one of five compounds: 0.5% quercetin, catechin, or epicatechin; or 1% cocoa powder or lignin. The fat source was polyunsaturated oil, increased from 7 to 11.05% (w/w with diet) to maximize lipid peroxidation while staying within a physiological range. After 7 weeks of treatment, animals were sacrificed with plasma and hearts analyzed to determine differences in F2-isoprostane levels. None of the treatment compounds significantly decreased plasma or heart F2-isoprostanes compared to the control beyond the significant protection displayed by alpha-tocopherol. We conclude that under these experimental conditions, quercetin, catechin, and epicatechin do not suppress lipid peroxidation in vivo.

MeSH Terms (13)

Animals Antioxidants Body Weight Dietary Supplements F2-Isoprostanes Flavonoids Heart Lipid Peroxidation Male Myocardium Organ Size Rats Rats, Sprague-Dawley

Connections (1)

This publication is referenced by other Labnodes entities: